US5552115A
(en)
*
|
1986-02-06 |
1996-09-03 |
Steris Corporation |
Microbial decontamination system with components porous to anti-microbial fluids
|
EP0533285A1
(en)
*
|
1991-09-17 |
1993-03-24 |
Rockwool/ Grodan B.V. |
Active drainage system
|
NL9400789A
(nl)
*
|
1994-05-11 |
1995-12-01 |
Rockwool Grodan Bv |
Drainagesysteem voor actieve en passieve vloeistofdrainage.
|
EP1157607A3
(en)
|
2000-05-26 |
2002-11-20 |
Hirose Co., Limited |
Method and apparatus for growing ornamental plants by hydroponic cultivation
|
GB0117182D0
(en)
*
|
2001-07-13 |
2001-09-05 |
Rockwool Int |
Method and system for growing plants
|
GB0117183D0
(en)
*
|
2001-07-13 |
2001-09-05 |
Rockwool Int |
Method and apparatus for growing plants
|
GB0300701D0
(en)
*
|
2003-01-13 |
2003-02-12 |
Rockwool Int |
Method and apparatus for growing plants
|
GB0409787D0
(en)
|
2004-04-30 |
2004-06-09 |
Rockwool Int |
Method and apparatus for growing plants
|
FR2870549B1
(fr)
*
|
2004-05-24 |
2006-08-25 |
Financ Elysees Balzac Sa |
Non-tisse recurant, outil d'entretien incorporant dans sa structure ledit non-tisse recurant, fabrication
|
WO2009126933A2
(en)
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
US8962580B2
(en)
|
2008-09-23 |
2015-02-24 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
AU2010221419B2
(en)
|
2009-03-02 |
2015-10-01 |
Alnylam Pharmaceuticals, Inc. |
Nucleic acid chemical modifications
|
WO2011100131A2
(en)
|
2010-01-28 |
2011-08-18 |
Alnylam Pharmacuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
WO2011109427A2
(en)
|
2010-03-01 |
2011-09-09 |
Alnylam Pharmaceuticals, Inc. |
Improving the biological activity of sirna through modulation of its thermodynamic profile
|
WO2011133868A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
US10913767B2
(en)
|
2010-04-22 |
2021-02-09 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising acyclic and abasic nucleosides and analogs
|
BR122019026068B8
(pt)
|
2011-06-21 |
2022-10-18 |
Alnylam Pharmaceuticals |
Ácido ribonucleico de fita dupla (dsrna) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de angptl3 em uma célula
|
CA2856289A1
(en)
|
2011-11-18 |
2013-05-23 |
Alnylam Pharmaceuticals, Inc. |
Modified rnai agents
|
SG10201912170WA
(en)
|
2011-11-18 |
2020-02-27 |
Alnylam Pharmaceuticals Inc |
Rnai Agents, Compositions And Methods Of Use Thereof For Treating Transthyretin (TTR) Associated Diseases
|
SI2809849T2
(sl)
|
2012-01-30 |
2021-02-26 |
Rockwool International A/S |
Odtočni element
|
WO2014022739A2
(en)
|
2012-08-03 |
2014-02-06 |
Alnylam Pharmaceuticals, Inc. |
Modified rnai agents
|
EP3336187A1
(en)
|
2012-12-05 |
2018-06-20 |
Alnylam Pharmaceuticals, Inc. |
Pcsk9 irna compositions and methods of use thereof
|
SG11201507400SA
(en)
|
2013-03-14 |
2015-10-29 |
Alnylam Pharmaceuticals Inc |
Complement component c5 irna compositions and methods of use thereof
|
LT2999785T
(lt)
|
2013-05-22 |
2018-07-25 |
Alnylam Pharmaceuticals, Inc. |
Serpina1 irna kompozicijos ir jų panaudojimo būdai
|
TW202342750A
(zh)
|
2013-05-22 |
2023-11-01 |
美商阿尼拉製藥公司 |
TMPRSS6 iRNA組成物及其使用方法
|
US9402353B2
(en)
*
|
2013-06-10 |
2016-08-02 |
Waterpulse, Inc. |
Injector style irrigation system
|
TW201610151A
(zh)
|
2013-09-23 |
2016-03-16 |
阿尼拉製藥公司 |
治療或預防與甲狀腺素運載蛋白相關疾病之方法
|
US10119136B2
(en)
|
2014-01-09 |
2018-11-06 |
Alnylam Pharmaceuticals, Inc. |
RNAi agents modified at the 4′-C position
|
CA2938857A1
(en)
|
2014-02-11 |
2015-08-20 |
Alnylam Pharmaceuticals, Inc. |
Ketohexokinase (khk) irna compositions and methods of use thereof
|
CN112301031A
(zh)
|
2014-05-22 |
2021-02-02 |
阿尔尼拉姆医药品有限公司 |
血管紧张素原(AGT)iRNA组合物及其使用方法
|
KR102630289B1
(ko)
|
2014-08-20 |
2024-01-31 |
알닐람 파마슈티칼스 인코포레이티드 |
변형 이중-가닥 rna 제제
|
EP3191591A1
(en)
|
2014-09-12 |
2017-07-19 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting complement component c5 and methods of use thereof
|
WO2016061487A1
(en)
|
2014-10-17 |
2016-04-21 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
|
EP3212794B1
(en)
|
2014-10-30 |
2021-04-07 |
Genzyme Corporation |
Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
|
EP3221451A1
(en)
|
2014-11-17 |
2017-09-27 |
Alnylam Pharmaceuticals, Inc. |
Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof
|
CA2976445A1
(en)
|
2015-02-13 |
2016-08-18 |
Alnylam Pharmaceuticals, Inc. |
Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
|
MX2017012610A
(es)
|
2015-04-08 |
2018-03-16 |
Alnylam Pharmaceuticals Inc |
Composiciones y metodos para inhibir la expresion del gen lect2.
|
EA201792444A1
(ru)
|
2015-05-06 |
2018-06-29 |
Элнилэм Фармасьютикалз, Инк. |
КОМПОЗИЦИИ НА ОСНОВЕ iRNA ДЛЯ ФАКТОРА XII (ФАКТОРА ХАГЕМАНА) (F12), ПЛАЗМЕННОГО КАЛЛИКРЕИНА B (ФАКТОРА ФЛЕТЧЕРА) 1 (KLKB1) И КИНИНОГЕНА 1 (KNG1) И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
WO2016201301A1
(en)
|
2015-06-12 |
2016-12-15 |
Alnylam Pharmaceuticals, Inc. |
Complement component c5 irna compositions and methods of use thereof
|
WO2016205323A1
(en)
|
2015-06-18 |
2016-12-22 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
|
WO2017048620A1
(en)
|
2015-09-14 |
2017-03-23 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (pnpla3) and methods of use thereof
|
WO2017100542A1
(en)
|
2015-12-10 |
2017-06-15 |
Alnylam Pharmaceuticals, Inc. |
Sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof
|
JP2019518028A
(ja)
|
2016-06-10 |
2019-06-27 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
補体成分C5iRNA組成物及び発作性夜間血色素尿症(PNH)を処置するためのその使用方法
|
WO2020117840A2
(en)
|
2018-12-05 |
2020-06-11 |
Empirico Inc. |
Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions
|
USD872638S1
(en)
*
|
2019-07-04 |
2020-01-14 |
Deryck Yin |
Planter
|